“Launch of Incovacc today is an important milestone under Atma Nirbhar Bharat efforts, Mandaviya said. “Today, 65% of vaccines for the world are contributed from India. In the global dialogue, India’s manufacturing, research and innovation capabilities are admired in the world. India will not be just known for pharmacy of the world, but will be known for research and innovation too.”
Incovacc will be rolled out as a booster dose for adults aged 18 years and older. Hyderabad-based Bharat Biotech has made it available on CoWin, priced at Rs 800 per dose for the private market and Rs 325 for central and state governments.
The vaccine will be available in private hospitals and the government is unlikely to procure it.
The Central Drugs Laboratory in Kasauli, the government’s nodal laboratory, has cleared three batches of the vaccine, the people cited earlier said.
Executives of some private hospitals said talks have been initiated with Bharat Biotech to procure Incovacc in small quantities.
“We are in touch with the company and will buy it in small quantities. Though the demand has not increased for precaution doses, we want to give another option to those who want a heterologous booster,” said a senior executive at a private hospital in Delhi.
(With inputs from health)
[title_words_as_hashtags
